Celexa and Gastric polyps - a phase IV clinical study of FDA data

Summary:

Gastric polyps is reported as a side effect among people who take Celexa (citalopram hydrobromide), especially for people who are female, 50-59 old, also take Prilosec, and have Metastases to bone.

The phase IV clinical study analyzes which people have Gastric polyps when taking Celexa. It is created by eHealthMe based on reports of 49,596 people who have side effects when taking Celexa from the FDA, and is updated regularly.

What is Celexa?

Celexa has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 56,391 Celexa users. Check the latest studies of Celexa.

What is Gastric polyps?

Gastric polyps (abnormal growth of stomach tissue projecting from a mucous membrane) is found to be associated with 458 drugs and 492 conditions by eHealthMe. Check the latest studies of Gastric polyps.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

49,596 people reported to have side effects when taking Celexa.
Among them, 41 people (0.08%) have Gastric polyps.

Among these 41 people:

What is the gender of people who have Gastric polyps when taking Celexa? *

female: 95.12 %
male: 4.88 %

What is the age of people who have Gastric polyps when taking Celexa? *

What are other drugs people take besides Celexa? *

What are other side effects people have besides Gastric polyps? *

Injury: 34 people, 82.93%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 34 people, 82.93%
Back Pain: 33 people, 80.49%
Osteonecrosis Of Jaw (death of bone of jaw): 33 people, 80.49%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 33 people, 80.49%
Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body): 33 people, 80.49%
Pain: 33 people, 80.49%
Atelectasis (partial or complete collapse of the lung): 33 people, 80.49%
Anaemia (lack of blood): 32 people, 78.05%
Hyperlipidaemia (presence of excess lipids in the blood): 32 people, 78.05%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 21 people, 51.22%
Insomnia (sleeplessness): 11 people, 26.83%
Herpes Virus Infection: 11 people, 26.83%
Ovarian Cancer (cancer of ovary): 10 people, 24.39%
Nausea (feeling of having an urge to vomit): 10 people, 24.39%
Muscle Aches (muscle pain): 10 people, 24.39%
Osteoporosis (bones weak and more likely to break): 6 people, 14.63%
Breast Cancer: 5 people, 12.20%
High Blood Cholesterol: 2 people, 4.88%
Breast Cancer Metastatic: 2 people, 4.88%

* Approximation only. Some reports may have incomplete information.

Do you take Celexa and have Gastric polyps?

- Check whether Gastric polyps is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Celexa:

Celexa (56,391 reports)

Gastric polyps treatments and more:

Gastric polyps (3,159 reports)

Browse all side effects of Celexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gastric polyps:

Gastric polyps (458 drugs)

Browse all the conditions that are associated with Gastric polyps:

Gastric polyps (492 conditions)

Related publications that referenced our studies

Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .
Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on citalopram hydrobromide (the active ingredients of Celexa) and Celexa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.